To assess whether the restoration of chemosensitivity in MDR cells following APC activation was independent of species and cancer type, human MCF7 ER+ breast cancer cells were selected for resistance to TAM according to our published methods [27,33]. The gene discussed is APC; the disease is breast carcinoma.